This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jaeck, D. Search for Related Content PubMed PubMed Citation Articles by Jaeck, D.

The Significance of Hepatic Pedicle Lymph Nodes Metastases in Surgical Management of Colorectal Liver Metastases and of Other Liver Malignancies

From the Centre de Chirurgie Viscérale et de Transplantation, Hôpital de Hautepierre, Strasbourg, France.

Correspondence: Address correspondence and reprint requests to: Prof. Daniel Jaeck, Centre de Chirurgie Viscérale et de Transplantation, Hôpital de Hautepierre Strasbourg, Avenue Molière, 67098 Strasbourg Cedex, France; Fax: +33 3 88 12 72 86; E-mail: Daniel.Jaeck{at}chru-strasbourg.fr

ABSTRACT

Background: Surgical resection of colorectal liver metastases (CLM) is the only hope for cure, with a 5-year survival rate ranging from 20% to 54%. However, the resectability rate of CLM is reported to be <20%. This limitation is mainly due to insufficient remnant liver and to extrahepatic disease. Among extrahepatic locations, lymph node metastases are often considered indications of a very poor prognosis and a contra-indication to resection.

Methods and Results: Our studies showed that the prevalence of hepatic pedicle lymph node metastases ranges from 10% to 20%. When located near the hilum and along the hepatic pedicle (area 1) they should not be considered an absolute contra-indication to resection of CLM, and an extended lymphadenectomy should be performed. However, when they reach the celiac trunk (area 2), there is no survival benefit after resection of CLM. For other cases of liver malignancies, lymph node dissection seems justified only in cases of fibrolamellar hepatocellular carcinoma and in case of hilar cholangiocarcinoma. However, few data are available, and they are controversial.

Conclusions: There is a need for more evaluation of lymph node involvement, at least in patients with high risk of such an extension, i.e., patients with more than three metastases, located in segment 4 or 5. There is also a need for prospective trials in order to evaluate the survival benefit of liver resection in such circumstances and the impact of extensive lymphadenectomy.

Key Words: Colorectal liver metastasis • Hepatic pedicle lymph node involvement • Hepatic resection • Lymphadenectomy • Prognostic factors

This article has been cited by other articles:

				J. J. Bennett, C. R. Schmidt, D. S. Klimstra, S. R. Grobmyer, N. M. Ishill, M. D'Angelica, R. P. DeMatteo, Y. Fong, L. H. Blumgart, and W. R. Jarnagin Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases Ann. Surg. Oncol., April 1, 2008; 15(4): 1130 - 1136. [Abstract] [Full Text] [PDF]

				S. Mulier, Y. Ni, J. Jamart, L. Michel, G. Marchal, and T. Ruers Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial? Ann. Surg. Oncol., January 1, 2008; 15(1): 144 - 157. [Abstract] [Full Text] [PDF]

				T. M. Pawlik, R. D. Schulick, and M. A. Choti Expanding Criteria for Resectability of Colorectal Liver Metastases Oncologist, January 1, 2008; 13(1): 51 - 64. [Abstract] [Full Text] [PDF]

				G. Poston, R. Adam, and J.-N. Vauthey Downstaging or Downsizing: Time for a New Staging System in Advanced Colorectal Cancer? J. Clin. Oncol., June 20, 2006; 24(18): 2702 - 2706. [Full Text] [PDF]

				W. J. Lesterhuis, I. J. M. de Vries, D. H. Schuurhuis, A. C. I. Boullart, J. F. M. Jacobs, A. J. de Boer, N. M. Scharenborg, H. M. H. Brouwer, M. W. M. M. van de Rakt, C. G. Figdor, et al. Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests Ann. Onc., June 1, 2006; 17(6): 974 - 980. [Abstract] [Full Text] [PDF]